Variant Classification
Variant Classification - Related Videos
02:30
Histone Variants at the Centromere
0 Views •
2020
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
08:04
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
0 Views •
2025
This study introduces a multiscale framework, spanning from DNA to protein function and neural behavior. It presents a novel approach for investigating predicted pathogenic mutations in the GABAA receptor subunit, hypothesizing that epileptogenic mutations and proximal mutations, predicted as pathogenic, may produce similar effects on the CA1 pyramidal neuron model.
14:06
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
0 Views •
Cited by 10 •
2012
Pooled DNA sequencing is a fast and cost-effective strategy to detect rare variants associated with complex phenotypes in large cohorts. Here we describe the computational analysis of pooled, next-generation sequencing of 32 cancer-related genes using the SPLINTER software package. This method is scalable, and applicable to any phenotype of interest.
03:20
Generation of Influenza Virus Escape Variants against Neutralizing Antibodies
0 Views •
2025
This video demonstrates a technique for generating escape variants of neutralizing influenza virus monoclonal antibodies. Antibody-neutralized virus suspension is injected into embryonated chicken eggs to propagate escape variants selectively. This results in a virus population predominantly of escape variants, confirmed via a Hemagglutination assay.
07:55
Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
0 Views •
Cited by 10 •
2017
We describe a method by which we identify critical residues required for the binding of human or murine monoclonal antibodies that target the viral hemagglutinin of influenza A viruses. The protocol can be adapted to other virus surface glycoproteins and their corresponding neutralizing antibodies.
FAQs
Variant Classification relies on converging evidence rather than a single observation. Analysts compare sequence findings with population frequency, computational predictions, functional assay results, clinical observations, and tumor context. Agreement among these sources can strengthen an interpretation, while conflicting or limited evidence may prevent a definitive conclusion. This integrated approach helps connect a genetic change with its potential biological and clinical significance.
Germline variants and somatic changes represent different biological contexts. A germline alteration is considered in relation to inherited cancer predisposition, whereas an acquired somatic change is evaluated within the tumor that developed it. Keeping these categories separate helps researchers interpret cancer risk, tumor development, and possible treatment relevance without treating every detected alteration as evidence of inherited susceptibility.
A variant may remain of uncertain significance when available evidence does not consistently support a benign or pathogenic interpretation. This can occur when population data, computational predictions, functional assays, clinical observations, or tumor information are limited or contradictory. The classification is therefore provisional rather than conclusive, and later evidence may support a revised interpretation.
Tumor context provides information about where and how an alteration appears within cancer research. Analysts consider the change alongside the characteristics of the tumor and other available observations, rather than interpreting the sequence result in isolation. This context can help clarify whether a mutation may contribute to tumor development, support biomarker discovery, or inform investigation of treatment selection.
A typical process begins with sequence data identifying a genetic change, followed by review of population frequency and computational predictions. Analysts then incorporate results from functional assays, clinical observations, and tumor context. These evidence sources are integrated to assign an interpretation, while the distinction between germline and somatic origin is maintained. The resulting classification supports consistent communication across research and clinical settings.
The approach is useful when researchers need to evaluate cancer-predisposing alterations, understand how mutations may influence tumor development, or investigate potential biomarkers. It can also contribute to treatment-selection research by organizing evidence about the significance of tumor-associated changes. Consistent interpretations allow findings to be communicated more clearly across studies and between research and clinical environments.